STOCK TITAN

[SCHEDULE 13G] Profusa, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary

Schedule 13G filed 24-Jul-2025 shows a group comprised of Ascent Partners Fund LLC, Dominion Capital and related entities plus individuals Mikhail Gurevich, Gennadiy Gurevich and Alon Brenner collectively own 3,359,068 Profusa (PFSA) common shares, equal to 9.99 % of shares outstanding as of 11-Jul-2025. The stake includes up to 820,475 shares issuable on conversion of a convertible promissory note; the note carries a 9.99 % ownership “blocker,” limiting additional conversions. All voting and dispositive power is reported as shared; no party claims sole control.

The percentage is calculated against the company’s 32,788,877 shares outstanding disclosed in a 18-Jul-2025 8-K. Because the filing is on Form 13G rather than 13D, the group certifies the position is passive and not intended to influence control. Exhibit 1 contains a joint filing agreement. The presence of an institutional investor group near the 10 % threshold signals outside confidence but also points to potential future dilution should the remaining note principal be converted once the blocker is lifted or expires.

Schedule 13G depositato il 24-lug-2025 mostra che un gruppo composto da Ascent Partners Fund LLC, Dominion Capital e entità correlate, insieme agli individui Mikhail Gurevich, Gennadiy Gurevich e Alon Brenner, possiede collettivamente 3.359.068 azioni ordinarie Profusa (PFSA), pari al 9,99% delle azioni in circolazione al 11-lug-2025. La partecipazione include fino a 820.475 azioni convertibili da un pagherò convertibile; tale pagherò prevede un limite di proprietà del 9,99%, che limita ulteriori conversioni. Tutti i poteri di voto e di disposizione sono riportati come condivisi; nessuna parte rivendica il controllo esclusivo.

La percentuale è calcolata sulle 32.788.877 azioni in circolazione della società, come indicato in un 8-K del 18-lug-2025. Poiché la dichiarazione è su modulo 13G e non 13D, il gruppo certifica che la posizione è passiva e non intende influenzare il controllo. L'Esibizione 1 contiene un accordo di deposito congiunto. La presenza di un gruppo di investitori istituzionali vicino alla soglia del 10% indica fiducia esterna, ma evidenzia anche una potenziale futura diluizione nel caso in cui il capitale residuo del pagherò venga convertito una volta che il limite sarà rimosso o scaduto.

Schedule 13G presentado el 24-jul-2025 muestra que un grupo compuesto por Ascent Partners Fund LLC, Dominion Capital y entidades relacionadas, junto con las personas Mikhail Gurevich, Gennadiy Gurevich y Alon Brenner, poseen colectivamente 3,359,068 acciones comunes de Profusa (PFSA), equivalentes al 9.99 % de las acciones en circulación al 11-jul-2025. La participación incluye hasta 820,475 acciones emitibles por conversión de un pagaré convertible; dicho pagaré tiene un límite de propiedad del 9.99 %, que restringe conversiones adicionales. Todo el poder de voto y disposición se reporta como compartido; ninguna parte reclama control exclusivo.

El porcentaje se calcula sobre las 32,788,877 acciones en circulación de la compañía, según se reveló en un formulario 8-K del 18-jul-2025. Debido a que la presentación es en el Formulario 13G y no 13D, el grupo certifica que la posición es pasiva y no busca influir en el control. El Anexo 1 contiene un acuerdo conjunto de presentación. La presencia de un grupo de inversores institucionales cerca del umbral del 10 % indica confianza externa, pero también señala una potencial dilución futura si el saldo restante del pagaré se convierte una vez que se levante o expire el límite.

Schedule 13G가 2025년 7월 24일 제출되었으며, Ascent Partners Fund LLC, Dominion Capital 및 관련 기관과 개인 Mikhail Gurevich, Gennadiy Gurevich, Alon Brenner로 구성된 그룹이 3,359,068주 Profusa (PFSA) 보통주를 공동으로 보유하고 있음을 보여줍니다. 이는 2025년 7월 11일 기준으로 발행 주식의 9.99%에 해당합니다. 이 지분에는 전환 사채 전환으로 발행 가능한 최대 820,475주가 포함되어 있으며, 해당 사채는 9.99% 소유 제한 ‘블로커’를 가지고 있어 추가 전환을 제한합니다. 모든 의결권 및 처분권은 공동 소유로 보고되었으며, 단독 통제권을 주장하는 당사자는 없습니다.

이 비율은 2025년 7월 18일 8-K 보고서에 공개된 회사의 32,788,877주 발행 주식을 기준으로 계산되었습니다. 제출서가 13D가 아닌 13G 양식임에 따라, 그룹은 해당 지분이 수동적이며 경영권에 영향을 미치려는 의도가 없음을 인증합니다. 첨부 문서 1에는 공동 제출 계약서가 포함되어 있습니다. 기관 투자자 그룹이 10% 임계치에 근접해 있다는 것은 외부 신뢰를 나타내지만, 블로커가 해제되거나 만료될 경우 남은 사채 원금이 전환될 수 있어 잠재적 미래 희석 가능성도 시사합니다.

Schedule 13G déposé le 24 juillet 2025 montre qu'un groupe composé d'Ascent Partners Fund LLC, Dominion Capital et entités associées ainsi que des individus Mikhail Gurevich, Gennadiy Gurevich et Alon Brenner détient collectivement 3 359 068 actions ordinaires Profusa (PFSA), soit 9,99 % des actions en circulation au 11 juillet 2025. La participation comprend jusqu'à 820 475 actions pouvant être émises lors de la conversion d'un billet convertible ; ce billet comporte un plafond de propriété de 9,99 %, limitant les conversions supplémentaires. Tous les droits de vote et de disposition sont déclarés partagés ; aucune partie ne revendique le contrôle exclusif.

Le pourcentage est calculé sur les 32 788 877 actions en circulation de la société, divulguées dans un formulaire 8-K du 18 juillet 2025. Étant donné que le dépôt est fait sur le formulaire 13G et non 13D, le groupe certifie que la position est passive et n'a pas l'intention d'influencer le contrôle. L'annexe 1 contient un accord de dépôt conjoint. La présence d'un groupe d'investisseurs institutionnels proche du seuil de 10 % témoigne d'une confiance extérieure, mais indique également un risque potentiel de dilution future si le principal restant du billet est converti une fois que le plafond sera levé ou expiré.

Schedule 13G, eingereicht am 24. Juli 2025, zeigt eine Gruppe bestehend aus Ascent Partners Fund LLC, Dominion Capital und verbundenen Einheiten sowie den Personen Mikhail Gurevich, Gennadiy Gurevich und Alon Brenner, die gemeinsam 3.359.068 Profusa (PFSA) Stammaktien besitzen, was 9,99 % der ausstehenden Aktien zum 11. Juli 2025 entspricht. Die Beteiligung umfasst bis zu 820.475 Aktien, die durch Umwandlung einer wandlungsfähigen Schuldverschreibung ausgegeben werden können; diese Schuldverschreibung unterliegt einer 9,99 % Besitzbeschränkung („Blocker“), die weitere Umwandlungen begrenzt. Alle Stimm- und Verfügungsrechte werden als gemeinsam gemeldet; keine Partei beansprucht die alleinige Kontrolle.

Der Prozentsatz basiert auf den 32.788.877 ausstehenden Aktien des Unternehmens, wie in einem 8-K vom 18. Juli 2025 angegeben. Da die Meldung auf Formular 13G und nicht 13D erfolgt, bestätigt die Gruppe, dass die Position passiv ist und keine Kontrolle beeinflussen soll. Anlage 1 enthält eine gemeinsame Einreichungsvereinbarung. Die Präsenz einer institutionellen Investorengruppe nahe der 10%-Schwelle signalisiert externes Vertrauen, weist jedoch auch auf eine potenzielle zukünftige Verwässerung hin, falls der verbleibende Schuldverschreibungsbetrag nach Aufhebung oder Ablauf des Blockers umgewandelt wird.

Positive
  • Institutional validation: A sophisticated investor group elected to hold nearly 10 % of PFSA, indicating confidence in the company’s prospects.
  • Passive filing: Use of Schedule 13G suggests no immediate activist pressure on management.
Negative
  • Dilution overhang: Remaining convertible note principal could add shares beyond the 9.99 % blocker, expanding the float.
  • Disclosure inconsistency: Item 4 lists 99.99 % ownership, conflicting with the 9.99 % figure elsewhere and requiring clarification.

Insights

TL;DR: 9.99 % passive stake signals confidence but flags dilution risk from convertible note.

The Ascent-Dominion group’s capped ownership introduces a sophisticated investor that may support Profusa’s capital needs. A passive 13G reduces governance overhang versus a 13D activist filing, yet the sizeable convertible note—already partly converted—could expand the float if the blocker is removed. Investors should watch for amendment filings that raise ownership or shift to a 13D, which would imply a strategic agenda.

TL;DR: Joint filers avoid control intent, keeping governance stable for now.

Because voting/dispositive power is shared and limited to under 10 %, the group sidesteps short-swing profit rules and additional filing burdens. Management retains control leverage, but any future ownership increase past the 10 % line would trigger heightened disclosure and potential board negotiation. The typo showing 99.99 % in Item 4 warrants clarification but is unlikely material.

Schedule 13G depositato il 24-lug-2025 mostra che un gruppo composto da Ascent Partners Fund LLC, Dominion Capital e entità correlate, insieme agli individui Mikhail Gurevich, Gennadiy Gurevich e Alon Brenner, possiede collettivamente 3.359.068 azioni ordinarie Profusa (PFSA), pari al 9,99% delle azioni in circolazione al 11-lug-2025. La partecipazione include fino a 820.475 azioni convertibili da un pagherò convertibile; tale pagherò prevede un limite di proprietà del 9,99%, che limita ulteriori conversioni. Tutti i poteri di voto e di disposizione sono riportati come condivisi; nessuna parte rivendica il controllo esclusivo.

La percentuale è calcolata sulle 32.788.877 azioni in circolazione della società, come indicato in un 8-K del 18-lug-2025. Poiché la dichiarazione è su modulo 13G e non 13D, il gruppo certifica che la posizione è passiva e non intende influenzare il controllo. L'Esibizione 1 contiene un accordo di deposito congiunto. La presenza di un gruppo di investitori istituzionali vicino alla soglia del 10% indica fiducia esterna, ma evidenzia anche una potenziale futura diluizione nel caso in cui il capitale residuo del pagherò venga convertito una volta che il limite sarà rimosso o scaduto.

Schedule 13G presentado el 24-jul-2025 muestra que un grupo compuesto por Ascent Partners Fund LLC, Dominion Capital y entidades relacionadas, junto con las personas Mikhail Gurevich, Gennadiy Gurevich y Alon Brenner, poseen colectivamente 3,359,068 acciones comunes de Profusa (PFSA), equivalentes al 9.99 % de las acciones en circulación al 11-jul-2025. La participación incluye hasta 820,475 acciones emitibles por conversión de un pagaré convertible; dicho pagaré tiene un límite de propiedad del 9.99 %, que restringe conversiones adicionales. Todo el poder de voto y disposición se reporta como compartido; ninguna parte reclama control exclusivo.

El porcentaje se calcula sobre las 32,788,877 acciones en circulación de la compañía, según se reveló en un formulario 8-K del 18-jul-2025. Debido a que la presentación es en el Formulario 13G y no 13D, el grupo certifica que la posición es pasiva y no busca influir en el control. El Anexo 1 contiene un acuerdo conjunto de presentación. La presencia de un grupo de inversores institucionales cerca del umbral del 10 % indica confianza externa, pero también señala una potencial dilución futura si el saldo restante del pagaré se convierte una vez que se levante o expire el límite.

Schedule 13G가 2025년 7월 24일 제출되었으며, Ascent Partners Fund LLC, Dominion Capital 및 관련 기관과 개인 Mikhail Gurevich, Gennadiy Gurevich, Alon Brenner로 구성된 그룹이 3,359,068주 Profusa (PFSA) 보통주를 공동으로 보유하고 있음을 보여줍니다. 이는 2025년 7월 11일 기준으로 발행 주식의 9.99%에 해당합니다. 이 지분에는 전환 사채 전환으로 발행 가능한 최대 820,475주가 포함되어 있으며, 해당 사채는 9.99% 소유 제한 ‘블로커’를 가지고 있어 추가 전환을 제한합니다. 모든 의결권 및 처분권은 공동 소유로 보고되었으며, 단독 통제권을 주장하는 당사자는 없습니다.

이 비율은 2025년 7월 18일 8-K 보고서에 공개된 회사의 32,788,877주 발행 주식을 기준으로 계산되었습니다. 제출서가 13D가 아닌 13G 양식임에 따라, 그룹은 해당 지분이 수동적이며 경영권에 영향을 미치려는 의도가 없음을 인증합니다. 첨부 문서 1에는 공동 제출 계약서가 포함되어 있습니다. 기관 투자자 그룹이 10% 임계치에 근접해 있다는 것은 외부 신뢰를 나타내지만, 블로커가 해제되거나 만료될 경우 남은 사채 원금이 전환될 수 있어 잠재적 미래 희석 가능성도 시사합니다.

Schedule 13G déposé le 24 juillet 2025 montre qu'un groupe composé d'Ascent Partners Fund LLC, Dominion Capital et entités associées ainsi que des individus Mikhail Gurevich, Gennadiy Gurevich et Alon Brenner détient collectivement 3 359 068 actions ordinaires Profusa (PFSA), soit 9,99 % des actions en circulation au 11 juillet 2025. La participation comprend jusqu'à 820 475 actions pouvant être émises lors de la conversion d'un billet convertible ; ce billet comporte un plafond de propriété de 9,99 %, limitant les conversions supplémentaires. Tous les droits de vote et de disposition sont déclarés partagés ; aucune partie ne revendique le contrôle exclusif.

Le pourcentage est calculé sur les 32 788 877 actions en circulation de la société, divulguées dans un formulaire 8-K du 18 juillet 2025. Étant donné que le dépôt est fait sur le formulaire 13G et non 13D, le groupe certifie que la position est passive et n'a pas l'intention d'influencer le contrôle. L'annexe 1 contient un accord de dépôt conjoint. La présence d'un groupe d'investisseurs institutionnels proche du seuil de 10 % témoigne d'une confiance extérieure, mais indique également un risque potentiel de dilution future si le principal restant du billet est converti une fois que le plafond sera levé ou expiré.

Schedule 13G, eingereicht am 24. Juli 2025, zeigt eine Gruppe bestehend aus Ascent Partners Fund LLC, Dominion Capital und verbundenen Einheiten sowie den Personen Mikhail Gurevich, Gennadiy Gurevich und Alon Brenner, die gemeinsam 3.359.068 Profusa (PFSA) Stammaktien besitzen, was 9,99 % der ausstehenden Aktien zum 11. Juli 2025 entspricht. Die Beteiligung umfasst bis zu 820.475 Aktien, die durch Umwandlung einer wandlungsfähigen Schuldverschreibung ausgegeben werden können; diese Schuldverschreibung unterliegt einer 9,99 % Besitzbeschränkung („Blocker“), die weitere Umwandlungen begrenzt. Alle Stimm- und Verfügungsrechte werden als gemeinsam gemeldet; keine Partei beansprucht die alleinige Kontrolle.

Der Prozentsatz basiert auf den 32.788.877 ausstehenden Aktien des Unternehmens, wie in einem 8-K vom 18. Juli 2025 angegeben. Da die Meldung auf Formular 13G und nicht 13D erfolgt, bestätigt die Gruppe, dass die Position passiv ist und keine Kontrolle beeinflussen soll. Anlage 1 enthält eine gemeinsame Einreichungsvereinbarung. Die Präsenz einer institutionellen Investorengruppe nahe der 10%-Schwelle signalisiert externes Vertrauen, weist jedoch auch auf eine potenzielle zukünftige Verwässerung hin, falls der verbleibende Schuldverschreibungsbetrag nach Aufhebung oder Ablauf des Blockers umgewandelt wird.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of common stock, par value $0.0001 per share of the issuer (the "Common Stock") set forth on rows (6), (8) and (9) above includes the conversion, up to the Blocker (as defined in this footnote) amount, of a convertible promissory note (the "Convertible Note") directly and indirectly held by the reporting person, which Convertible Note is subject to a maximum 9.99% beneficial ownership limitation provision contained therein (the "Blocker"). In Row (11) the percentage is based on (i) 32,788,877 shares of Common Stock outstanding, as reported by the issuer in its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on July 18, 2025 (the "Form 8-K"), and (ii) 820,475 shares of Common Stock issuable upon partial conversion of the Convertible Note directly and indirectly held by the reporting person.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes the conversion, up to the Blocker amount, of the Convertible Note directly held by the reporting person, which Convertible Note is subject to the Blocker. In Row (11) the percentage is based on (i) 32,788,877 shares of Common Stock outstanding, as reported by the issuer in its Form 8-K, and (ii) 820,475 shares of Common Stock issuable upon partial conversion of the Convertible Note directly held by the reporting person.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes the conversion, up to the Blocker amount, of the Convertible Note directly and indirectly held by the reporting person, which Convertible Note is subject to the Blocker. In Row (11) the percentage is based on (i) 32,788,877 shares of Common Stock outstanding, as reported by the issuer in its Form 8-K, and (ii) 820,475 shares of Common Stock issuable upon partial conversion of the Convertible Note directly and indirectly held by the reporting person.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes the conversion, up to the Blocker amount, of the Convertible Note directly and indirectly held by the reporting person, which Convertible Note is subject to the Blocker. In Row (11) the percentage is based on (i) 32,788,877 shares of Common Stock outstanding, as reported by the issuer in its Form 8-K, and (ii) 820,475 shares of Common Stock issuable upon partial conversion of the Convertible Note directly and indirectly held by the reporting person.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes the conversion, up to the Blocker amount, of the Convertible Note directly and indirectly held by the reporting person, which Convertible Note is subject to the Blocker. In Row (11) the percentage is based on (i) 32,788,877 shares of Common Stock outstanding, as reported by the issuer in its Form 8-K, and (ii) 820,475 shares of Common Stock issuable upon partial conversion of the Convertible Note directly and indirectly held by the reporting person.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes the conversion, up to the Blocker amount, of the Convertible Note directly held by the reporting person, which Convertible Note is subject to the Blocker. In Row (11) the percentage is based on (i) 32,788,877 shares of Common Stock outstanding, as reported by the issuer in its Form 8-K, and (ii) 820,475 shares of Common Stock issuable upon partial conversion of the Convertible Note directly held by the reporting person.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes the conversion, up to the Blocker amount, of the Convertible Note directly and indirectly held by the reporting person, which Convertible Note is subject to the Blocker. In Row (11) the percentage is based on (i) 32,788,877 shares of Common Stock outstanding, as reported by the issuer in its Form 8-K, and (ii) 820,475 shares of Common Stock issuable upon partial conversion of the Convertible Note directly and indirectly held by the reporting person.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes the conversion, up to the Blocker amount, of the Convertible Note directly and indirectly held by the reporting person, which Convertible Note is subject to the Blocker. In Row (11), the percentage is based on (i) 32,788,877 shares of Common Stock outstanding, as reported by the issuer in its Form 8-K, and (ii) 820,475 shares of Common Stock issuable upon partial conversion of the Convertible Note directly held by the reporting person.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes the conversion, up to the Blocker amount, of the Convertible Note directly and indirectly held by the reporting person, which Convertible Note is subject to the Blocker. In Row (11), the percentage is based on (i) 32,788,877 shares of Common Stock outstanding, as reported by the issuer in its Form 8-K, and (ii) 820,475 shares of Common Stock issuable upon partial conversion of the Convertible Note directly held by the reporting person.


SCHEDULE 13G



Ascent Partners Fund LLC
Signature:/s/ Ascent Partners Fund LLC
Name/Title:Mikhail Gurevich, signatory for managing member of managing member
Date:07/24/2025
Ascent Partners LLC
Signature:/s/ Ascent Partners LLC
Name/Title:Mikhail Gurevich, signatory for managing member
Date:07/24/2025
Dominion Capital LLC
Signature:/s/ Dominion Capital LLC
Name/Title:Mikhail Gurevich, Managing Member of Dominion Capital Holdings LLC, Manager of Dominion Capital GP LLC, Manager of Dominion Capital LLC
Date:07/24/2025
Dominion Capital GP LLC
Signature:/s/ Dominion Capital GP LLC
Name/Title:Mikhail Gurevich, Managing Member of Dominion Capital Holdings LLC, Manager of Dominion Capital GP LLC
Date:07/24/2025
Dominion Capital Holdings LLC
Signature:/s/ Dominion Capital Holdings LLC
Name/Title:Mikhail Gurevich, Managing Member
Date:07/24/2025
Masada Group Holdings LLC
Signature:/s/ Masada Group Holdings LLC
Name/Title:Alon Brenner, Managing Member
Date:07/24/2025
Mikhail Gurevich
Signature:/s/ Mikhail Gurevich
Name/Title:Mikhail Gurevich
Date:07/24/2025
Gennadiy Gurevich
Signature:/s/ Gennadiy Gurevich
Name/Title:Gennadiy Gurevich
Date:07/24/2025
Alon Brenner
Signature:Alon Brenner
Name/Title:Alon Brenner
Date:07/24/2025
Exhibit Information

Exhibit 1 - Joint Filing Agreement

NorthView Acquisition Corp

NASDAQ:PFSA

PFSA Rankings

PFSA Latest News

PFSA Latest SEC Filings

PFSA Stock Data

26.36M
27.72M
Surgical & Medical Instruments & Apparatus
NEW YORK